Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-03-11

FDA Approved: BRIMONIDINE TARTRATE — Original Application (Somerset Therapeutics, LLC)

View source ↗

Summary

FDA approved a generic Brimonidine tartrate ophthalmic product (Original Application) from Somerset Therapeutics, LLC to treat open-angle glaucoma and ocular hy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRIMONIDINE TARTRATE (brimonidine tartrate)

Snippet

ORIG AP for BRIMONIDINE TARTRATE (BRIMONIDINE TARTRATE)